AAON Reports Second Quarter Sales and Earnings
Aug 03, 2017 11:01 am UTC| Business
TULSA, Okla., Aug. 03, 2017 -- AAON, Inc. (NASDAQ:AAON) today announced its operating results for the second quarter and six months ended June 30, 2017. In the quarter ended June 30, 2017, net sales were $101.3...
CDW Reports Record Second Quarter Net Sales
Aug 03, 2017 11:01 am UTC| Business
Reinforces Power of Business Model and Confidence in Strategy (Dollars in millions, except per share amounts)Three Months Ended June 30, 2017Three Months Ended June 30, 2016% Chg.Six Months Ended June 30, 2017Six Months...
Kratos Receives $23 Million Radar System Contract Award
Aug 03, 2017 11:00 am UTC| Business
SAN DIEGO, Aug. 03, 2017 -- Kratos Defense Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that its Modular Systems Division (MSD) recently received an...
Bellicum Pharmaceuticals Appoints Gregory Naeve as Chief Business Officer
Aug 03, 2017 11:00 am UTC| Business
HOUSTON, Aug. 03, 2017 -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that Gregory...
Horizon Pharma plc Appoints Pascale Witz and James Shannon, M.D. to Board of Directors
Aug 03, 2017 11:00 am UTC| Business
DUBLIN, Ireland, Aug. 03, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and...
Sonic Foundry to Release Third Quarter 2017 Results on August 10, 2017
Aug 03, 2017 11:00 am UTC| Business
MADISON, Wis., Aug. 03, 2017 -- Sonic Foundry, Inc. (NASDAQ: SOFO), the trusted leader for video creation and management solutions, today announced it will release its fiscal third quarter 2017 results on Thursday,...
Trevena Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Aug 03, 2017 11:00 am UTC| Business
– OLINVO program on track for NDA submission in September/October 2017 – – First-time-in-human study of TRV250 for acute treatment of migraine remains on track; results expected in 2H 2017 – CHESTERBROOK, Pa., Aug....